Cite
APA Citation
Kay, J., Weinblatt, M., Keystone, E., Genovese, M., Ghil, J., Cheong, S., & Hong, E. (n.d.). oP0203 Impact of adalimumab serum concentration on efficacy and association between ANTI-DRUG antibodies and serum concentration: 24 week results from a phase III study comparing SB5 (an adalimumab biosimilar) with reference adalimumab in patients with rheumatoid arthritis. Annals of the rheumatic diseases, 76, 136. http://access.bl.uk/ark:/81055/vdc_100135160667.0x000059